CAS No. |
2254502-89-9 |
|---|---|
中文名称 |
HTT-D3 |
英文名称 |
HTT-D3 |
别名 |
HTT-D3 |
标准英文名 |
7-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-3-(1-ethylpiperidin-4-yl)-5-fluorocinnoline |
MDL No. |
MFCD35062486 |
分子式 |
C23H25FN6 |
分子量 |
404.49 |
精确分子量 |
404.21 |
SMILES |
FC1=CC(=CC=2N=NC(=CC12)C3CCN(CC)CC3)C4=NN5C=C(N=C5C(=C4)C)C |
标准SMILES |
CCN1CCC(CC1)C1=CC2C(F)=CC(=CC=2N=N1)C1C=C(C)C2=NC(C)=CN2N=1 |
用途 |
HTT-D3 is used as a potent and orally active Huntington (HTT) splicing modulator for Huntington's disease research; it reduces P-glycoprotein (P-gp) efflux and promotes the inclusion of a pseudoexon containing a premature termination codon, leading to HTT mRNA degradation and reduced HTT levels. |
InChIKey |
APXTULSKNLWAOS-UHFFFAOYSA-N |
|
|
评论 |
|---|